To address fragmented services and rising demand for allergy care in the UK, driven by increased prevalence and awareness.
Approach:
Key Findings:
One in three people in the UK is affected by allergic disease.
Allergy accounts for around 6% of GP visits and 10% of the GP prescribing budget.
The prevalence of allergic rhinitis and eczema has trebled since the 1970s.
Hospital admissions for anaphylaxis increased threefold from 1998 to 2018.
The UK has one of the worst allergy rates in the world.
Interpretation:
The strategy aims to establish allergy as a major chronic condition in health policy, improve care consistency across various sectors, and address health inequalities.
Limitations:
Inconsistent care pathways and limited specialist capacity.
Gaps in data and surveillance hinder effective implementation.
Need for better coordination across sectors.
Conclusion:
The launch marks the beginning of a broader program to translate evidence into measurable improvements in allergy care across the UK, with a focus on health inequalities and workforce sustainability.
Liam Heaney explains why closer collaboration between analytical chemists and sports scientists is needed to identify reliable markers of performance, recovery, and illness
